Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 42 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1983 adjusted for splits and dividends. The latest closing stock price for Amgen as of July 18, 2025 is 294.76.
  • The all-time high Amgen stock closing price was 329.11 on September 20, 2024.
  • The Amgen 52-week high stock price is 346.85, which is 17.7% above the current share price.
  • The Amgen 52-week low stock price is 253.30, which is 14.1% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 299.38.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 287.6487 254.9490 324.4920 254.2700 294.7600 15.01%
2024 293.2592 283.8460 329.1120 252.7440 256.2860 -6.77%
2023 234.7975 241.3680 275.3230 201.2850 274.9020 13.46%
2022 224.0643 202.7150 267.8800 197.7610 242.2810 20.43%
2021 203.6112 196.5840 226.4500 177.8460 201.1770 0.89%
2020 198.0202 202.6400 223.3020 154.8990 199.4120 -1.99%
2019 162.9521 157.1800 205.2560 138.3380 203.4590 27.60%
2018 151.9959 140.8370 170.5720 133.1230 159.4490 15.23%
2017 134.0879 116.6690 150.9450 116.6690 138.3710 22.27%
2016 119.2815 119.4240 135.0370 103.9730 113.1700 -7.57%
2015 118.1398 118.2250 131.9110 99.2415 122.4340 3.95%
2014 96.1089 83.9977 126.9130 80.7659 117.7810 42.33%
2013 74.7865 63.4899 85.7366 58.4548 82.7501 34.80%
2012 53.9376 44.7942 64.2163 44.5497 61.3890 36.83%
2011 38.8587 38.4141 45.2344 33.3798 44.8641 18.17%
2010 38.5533 39.9147 42.2797 34.8251 37.9646 -2.95%
2009 37.9750 40.7930 44.5410 31.1946 39.1195 -2.04%
2008 35.3652 32.2250 45.5645 27.6402 39.9355 24.35%
2007 40.0561 47.3002 52.4520 32.1143 32.1143 -32.02%
2006 48.8514 55.5708 55.5708 44.2022 47.2380 -13.38%
2005 48.3713 44.4511 59.5886 39.5551 54.5335 22.93%
2004 40.7310 43.1165 45.7996 36.4433 44.3612 3.82%
2003 42.4907 34.1059 49.4716 33.8017 42.7292 27.82%
2002 34.1556 39.0019 43.2064 21.4856 33.4282 -14.35%
2001 43.0917 43.4795 51.3024 35.6204 39.0296 -11.73%
2000 45.2732 43.5227 53.9388 35.4838 44.2143 6.45%
1999 25.6592 18.5631 44.8626 18.0877 41.5346 129.77%
1998 11.5528 9.3248 18.1309 8.1470 18.0768 93.19%
1997 9.6340 9.4436 11.8208 7.9417 9.3572 -0.46%
1996 10.1152 10.0703 11.3237 8.9034 9.4004 -8.42%
1995 7.0466 5.0352 10.2648 4.8839 10.2648 101.27%
1994 4.1853 4.2464 5.1324 3.0565 5.1000 19.19%
1993 3.6349 6.1048 6.1157 2.7229 4.2788 -29.91%
1992 5.5746 6.4615 6.7208 4.3220 6.1048 -6.77%
1991 3.9052 1.8369 6.5479 1.6640 6.5479 265.05%
1990 1.1382 0.7419 1.8260 0.6447 1.7937 154.10%
1989 0.6318 0.4610 0.8644 0.4592 0.7059 45.19%
1988 0.4406 0.4646 0.5150 0.3710 0.4862 8.87%
1987 0.4645 0.3404 0.6411 0.2341 0.4466 40.93%
1986 0.2914 0.1819 0.4088 0.1801 0.3169 62.93%
1985 0.1105 0.0685 0.2089 0.0667 0.1945 169.76%
1984 0.0791 0.1044 0.1189 0.0522 0.0721 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $158.494B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $213.340B 15.92
Gilead Sciences (GILD) United States $134.618B 13.98
Vertex Pharmaceuticals (VRTX) United States $118.078B 0.00
Bristol Myers Squibb (BMY) United States $96.381B 6.45
CSL (CSLLY) Australia $81.173B 0.00
GSK (GSK) United Kingdom $74.339B 8.90
Regeneron Pharmaceuticals (REGN) United States $58.573B 14.22
Alnylam Pharmaceuticals (ALNY) United States $41.793B 0.00
Argenex SE (ARGX) Netherlands $34.553B 94.10
BioNTech SE (BNTX) Germany $26.448B 0.00
Royalty Pharma (RPRX) United States $20.010B 8.45
Insmed (INSM) United States $19.456B 0.00
Biogen (BIIB) United States $18.315B 7.90
Illumina (ILMN) United States $15.219B 28.87
Genmab (GNMSF) Denmark $14.299B 14.62
Genmab (GMAB) Denmark $14.037B 15.74
Incyte (INCY) United States $13.136B 99.79
Exelixis (EXEL) United States $12.127B 20.59
Moderna (MRNA) United States $12.090B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.987B 17.85
QIAGEN (QGEN) Netherlands $10.750B 20.92
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Ascendis Pharma (ASND) Denmark $10.386B 0.00
Exact Sciences (EXAS) United States $9.519B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.930B 0.00
Bio-Techne Corp (TECH) United States $8.155B 30.42
Roivant Sciences (ROIV) United Kingdom $7.777B 0.00
Legend Biotech (LEGN) United States $7.643B 0.00
Revolution Medicines (RVMD) United States $7.134B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Halozyme Therapeutics (HALO) United States $6.956B 13.31
Jazz Pharmaceuticals (JAZZ) Ireland $6.830B 6.71
Anbio Biotechnology (NNNN) Germany $6.761B 0.00
Repligen (RGEN) United States $6.531B 73.11
TG Therapeutics (TGTX) United States $6.018B 157.96
Nuvalent (NUVL) United States $5.989B 0.00
Guardant Health (GH) United States $5.756B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.675B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.625B 0.00
Axsome Therapeutics (AXSM) United States $5.500B 0.00
Telix Pharmaceuticals (TLX) Australia $5.492B 0.00
Alkermes (ALKS) Ireland $4.818B 12.93
Vaxcyte (PCVX) United States $4.671B 0.00
Metsera (MTSR) United States $4.487B 0.00
Cytokinetics (CYTK) United States $4.446B 0.00
Merus (MRUS) Netherlands $4.378B 0.00
Krystal Biotech (KRYS) United States $4.262B 32.85
Akero Therapeutics (AKRO) United States $4.152B 0.00
Avidity Biosciences (RNA) United States $4.069B 0.00
ADMA Biologics Inc (ADMA) United States $3.994B 29.88
Zealand Pharma (ZLDPF) Denmark $3.965B 0.00
Scholar Rock Holding (SRRK) United States $3.866B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.776B 33.18
PTC Therapeutics (PTCT) United States $3.775B 6.57
Zai Lab (ZLAB) China $3.729B 0.00
Arcellx (ACLX) United States $3.725B 0.00
Viking Therapeutics (VKTX) United States $3.595B 0.00
Ascentage Pharma Group - (AAPG) China $3.519B 0.00
Protagonist Therapeutics (PTGX) United States $3.439B 73.97
MoonLake Immunotherapeutics (MLTX) Switzerland $3.398B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.068B 0.00
Immunovant (IMVT) United States $3.064B 0.00
Kymera Therapeutics (KYMR) United States $3.007B 0.00
Ligand Pharmaceuticals (LGND) United States $2.684B 0.00
Alvotech (ALVO) Luxembourg $2.602B 14.88
Mirum Pharmaceuticals (MIRM) United States $2.572B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.487B 0.00
Apellis Pharmaceuticals (APLS) United States $2.447B 0.00
ImmunityBio (IBRX) United States $2.427B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.424B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.374B 0.00
Agios Pharmaceuticals (AGIO) United States $2.317B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.315B 0.00
Bavarian Nordic (BVNRY) Denmark $2.250B 11.89
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.118B 0.00
Twist Bioscience (TWST) United States $2.107B 0.00
Beam Therapeutics (BEAM) United States $2.087B 0.00
CG Oncology (CGON) United States $2.039B 0.00
Denali Therapeutics (DNLI) United States $2.034B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.021B 13.44
Disc Medicine (IRON) United States $2.001B 0.00
Mesoblast (MESO) Australia $1.996B 0.00
Belite Bio (BLTE) United States $1.940B 0.00
IDEAYA Biosciences (IDYA) United States $1.891B 0.00
Amicus Therapeutics (FOLD) United States $1.835B 198.67
Immunocore Holdings (IMCR) United Kingdom $1.824B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.817B 0.00
Apogee Therapeutics (APGE) United States $1.810B 0.00
NovoCure (NVCR) Jersey $1.786B 0.00
Vericel (VCEL) United States $1.779B 1178.00
Arcutis Biotherapeutics (ARQT) United States $1.749B 0.00
Certara (CERT) United States $1.639B 30.61
Adaptive Biotechnologies (ADPT) United States $1.578B 0.00
Janux Therapeutics (JANX) United States $1.562B 0.00
89BIO (ETNB) United States $1.531B 0.00
Celldex Therapeutics (CLDX) United States $1.488B 0.00
Vera Therapeutics (VERA) United States $1.470B 0.00
ANI Pharmaceuticals (ANIP) United States $1.436B 14.80
Biohaven (BHVN) United States $1.435B 0.00
Travere Therapeutics (TVTX) United States $1.431B 0.00
Edgewise Therapeutics (EWTX) United States $1.424B 0.00
Cogent Biosciences (COGT) United States $1.422B 0.00
Sarepta Therapeutics (SRPT) United States $1.383B 0.00
Viridian Therapeutics (VRDN) United States $1.348B 0.00
AbCellera Biologics (ABCL) Canada $1.337B 0.00
WAVE Life Sciences (WVE) Singapore $1.297B 0.00
Dynavax Technologies (DVAX) United States $1.287B 76.57
GRAIL (GRAL) United States $1.266B 0.00
Intellia Therapeutics (NTLA) United States $1.249B 0.00
Liquidia Technologies (LQDA) United States $1.243B 0.00
Pharvaris (PHVS) Netherlands $1.215B 0.00
CureVac (CVAC) Germany $1.209B 5.86
Cidara Therapeutics (CDTX) United States $1.209B 0.00
MannKind (MNKD) United States $1.143B 23.50
Novavax (NVAX) United States $1.134B 2.64
Structure Therapeutics (GPCR) United States $1.104B 0.00
BGM Group (BGM) China $1.098B 0.00
Praxis Precision Medicines (PRAX) United States $1.097B 0.00
Sana Biotechnology (SANA) United States $1.044B 0.00
Pacira BioSciences (PCRX) United States $0.999B 9.51
Zymeworks (ZYME) United States $0.993B 0.00
Spyre Therapeutics (SYRE) United States $0.982B 0.00
Arcus Biosciences (RCUS) United States $0.969B 0.00
LENZ Therapeutics (LENZ) United States $0.949B 0.00
MiMedx (MDXG) United States $0.948B 22.93
Oric Pharmaceuticals (ORIC) United States $0.938B 0.00
Anavex Life Sciences (AVXL) United States $0.938B 0.00
Replimune (REPL) United States $0.932B 0.00
Mineralys Therapeutics (MLYS) United States $0.927B 0.00
Immunome (IMNM) United States $0.921B 0.00
GH Research (GHRS) Ireland $0.914B 0.00
Nurix Therapeutics (NRIX) United States $0.857B 0.00
UniQure (QURE) Netherlands $0.821B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.814B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Trevi Therapeutics (TRVI) United States $0.805B 0.00
NeoGenomics (NEO) United States $0.803B 0.00
Jyong Biotech (MENS) Taiwan $0.802B 0.00
Niagen Bioscience (NAGE) United States $0.801B 112.94
Geron (GERN) United States $0.790B 0.00
Nuvation Bio (NUVB) United States $0.783B 0.00
Maze Therapeutics (MAZE) United States $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Oculis Holding AG (OCS) Switzerland $0.764B 0.00
AnaptysBio (ANAB) United States $0.762B 0.00
ArriVent BioPharma (AVBP) United States $0.754B 0.00
Vir Biotechnology (VIR) United States $0.748B 0.00
Iovance Biotherapeutics (IOVA) United States $0.745B 0.00
Sionna Therapeutics (SION) United States $0.739B 0.00
CorMedix Inc (CRMD) United States $0.737B 49.36
Tango Therapeutics (TNGX) United States $0.734B 0.00
Immatics (IMTX) Germany $0.729B 0.00
Stoke Therapeutics (STOK) United States $0.722B 16.73
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.717B 0.00
Urogen Pharma (URGN) United States $0.705B 0.00
Pharming Group (PHAR) Netherlands $0.703B 0.00
MeiraGTx Holdings (MGTX) United States $0.693B 0.00
Gyre Therapeutics (GYRE) United States $0.676B 180.25
Mind Medicine (MindMed) (MNMD) United States $0.671B 0.00
Dianthus Therapeutics (DNTH) United States $0.656B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.641B 0.00
Abivax SA (ABVX) France $0.632B 0.00
Arbutus Biopharma (ABUS) United States $0.599B 0.00
Bicara Therapeutics (BCAX) United States $0.596B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.593B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.593B 0.00
Upstream Bio (UPB) United States $0.577B 0.00
Zenas BioPharma (ZBIO) United States $0.574B 0.00
Sage Therapeutics (SAGE) United States $0.570B 0.00
Septerna (SEPN) United States $0.559B 0.00
Keros Therapeutics (KROS) United States $0.558B 0.00
Prime Medicine (PRME) United States $0.555B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.555B 0.00
Tyra Biosciences (TYRA) United States $0.552B 0.00
Kura Oncology (KURA) United States $0.551B 0.00
Arvinas (ARVN) United States $0.536B 0.00
Rapport Therapeutics (RAPP) United States $0.536B 0.00
ATyr Pharma (ATYR) United States $0.533B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.530B 0.00
Opthea (OPT) Australia $0.525B 0.00
Precigen (PGEN) United States $0.520B 0.00
Celcuity (CELC) United States $0.515B 0.00
Solid Biosciences (SLDB) United States $0.495B 0.00
Terns Pharmaceuticals (TERN) United States $0.493B 0.00
Castle Biosciences (CSTL) United States $0.478B 32.43
PureTech Health (PRTC) United States $0.473B 0.00
Rezolute (RZLT) United States $0.461B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.445B 0.00
Cullinan Therapeutics (CGEM) United States $0.444B 0.00
Kamada (KMDA) Israel $0.428B 25.69
Erasca (ERAS) United States $0.425B 0.00
Fortrea Holdings (FTRE) United States $0.424B 11.73
Compass Therapeutics (CMPX) United States $0.415B 0.00
Fulcrum Therapeutics (FULC) United States $0.413B 0.00
Myriad Genetics (MYGN) United States $0.412B 0.00
REGENXBIO (RGNX) United States $0.409B 0.00
Tectonic Therapeutic (TECX) United States $0.409B 0.00
Eton Pharmaceuticals (ETON) United States $0.403B 0.00
Absci (ABSI) United States $0.398B 0.00
Cytek Biosciences (CTKB) United States $0.396B 0.00
MBX Biosciences (MBX) United States $0.393B 0.00
ITeos Therapeutics (ITOS) United States $0.393B 0.00
Northwest Biotherapeutics (NWBO) United States $0.387B 0.00
Gossamer Bio (GOSS) United States $0.386B 0.00
Vigil Neuroscience (VIGL) United States $0.385B 0.00
Emergent Biosolutions (EBS) United States $0.376B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.366B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.365B 74.25
Humacyte (HUMA) United States $0.361B 0.00
Inhibrx Biosciences (INBX) United States $0.354B 0.21
Foghorn Therapeutics (FHTX) United States $0.342B 0.00
Candel Therapeutics (CADL) United States $0.338B 0.00
Aura Biosciences (AURA) United States $0.337B 0.00
Abeona Therapeutics (ABEO) United States $0.337B 0.00
Prothena (PRTA) Ireland $0.337B 0.00
Astria Therapeutics (ATXS) United States $0.337B 0.00
Amarin (AMRN) Ireland $0.328B 0.00
Palvella Therapeutics (PVLA) United States $0.326B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.325B 0.00
Inventiva S.A (IVA) France $0.324B 0.00
Neurogene (NGNE) United States $0.319B 0.00
Cartesian Therapeutics (RNAC) United States $0.307B 0.00
XOMA Royalty (XOMA) United States $0.307B 0.00
Olema Pharmaceuticals (OLMA) United States $0.302B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.301B 0.00
Neumora Therapeutics (NMRA) United States $0.299B 0.00
Ocugen (OCGN) United States $0.298B 0.00
Kodiak Sciences (KOD) United States $0.291B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.291B 0.00
Benitec Biopharma (BNTC) United States $0.290B 0.00
Sagimet Biosciences (SGMT) United States $0.289B 0.00
Atea Pharmaceuticals (AVIR) United States $0.288B 0.00
Cardiff Oncology (CRDF) United States $0.285B 0.00
Monopar Therapeutics (MNPR) United States $0.284B 0.00
Verastem (VSTM) United States $0.284B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.282B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.281B 0.00
Lifecore Biomedical (LFCR) United States $0.277B 0.00
Vor Biopharma (VOR) $0.276B 0.00
DBV Technologies S.A (DBVT) France $0.274B 0.00
Allogene Therapeutics (ALLO) United States $0.273B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.268B 0.00
Crescent Biopharma (CBIO) United States $0.261B 0.00
ScPharmaceuticals (SCPH) United States $0.261B 0.00
Annexon (ANNX) United States $0.255B 0.00
Aardvark Therapeutics (AARD) United States $0.252B 0.00
Prima BioMed (IMMP) Australia $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.238B 0.00
Entrada Therapeutics (TRDA) United States $0.238B 7.73
Codexis (CDXS) United States $0.234B 0.00
Adherex Technologies (FENC) United States $0.233B 0.00
Editas Medicine (EDIT) United States $0.231B 0.00
Tvardi Therapeutics (TVRD) United States $0.230B 0.00
Alpha Teknova (TKNO) United States $0.228B 0.00
Semper Paratus Acquisition (TVGN) United States $0.226B 0.00
Design Therapeutics (DSGN) United States $0.226B 0.00
Ventyx Biosciences (VTYX) United States $0.225B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.222B 0.00
Adocia (ADOCY) France $0.216B 0.00
MaxCyte (MXCT) United States $0.215B 0.00
CARGO Therapeutics (CRGX) United States $0.211B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.195B 0.00
EnGene Holdings (ENGN) Canada $0.194B 0.00
Rapt Therapeutics (RAPT) United States $0.193B 0.00
CytomX Therapeutics (CTMX) United States $0.192B 4.97
Caribou Biosciences (CRBU) United States $0.191B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
BioStem Technologies (BSEM) $0.188B 7.65
Bright Minds Biosciences (DRUG) United States $0.184B 0.00
Alumis (ALMS) United States $0.181B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.181B 0.00
Voyager Therapeutics (VYGR) United States $0.179B 0.00
DiaMedica Therapeutics (DMAC) United States $0.179B 0.00
Black Diamond Therapeutics (BDTX) United States $0.178B 52.17
Innate Pharma S.A (IPHA) France $0.177B 0.00
SELLAS Life Sciences (SLS) United States $0.177B 0.00
I-Mab (IMAB) United States $0.171B 0.00
Instil Bio (TIL) United States $0.171B 0.00
Puma Biotechnology (PBYI) United States $0.169B 4.42
Agenus (AGEN) United States $0.169B 0.00
Kyverna Therapeutics (KYTX) United States $0.169B 0.00
BioAge Labs (BIOA) United States $0.166B 0.00
C4 Therapeutics (CCCC) United States $0.165B 0.00
Nuvectis Pharma (NVCT) United States $0.163B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.161B 0.00
Alpha Cognition (ACOG) Canada $0.160B 0.00
Alector (ALEC) United States $0.159B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.159B 0.00
Greenwich LifeSciences (GLSI) United States $0.155B 0.00
Anika Therapeutics (ANIK) United States $0.151B 0.00
Elicio Therapeutics (ELTX) United States $0.149B 0.00
Immuneering (IMRX) United States $0.149B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Theratechnologies (THTX) Canada $0.144B 0.00
Tenaya Therapeutics (TNYA) United States $0.143B 0.00
Compugen (CGEN) Israel $0.137B 0.00
Nkarta (NKTX) United States $0.136B 0.00
IO Biotech (IOBT) Denmark $0.135B 0.00
23andMe Holding (MEHCQ) United States $0.135B 0.00
Spero Therapeutics (SPRO) United States $0.133B 0.00
Zura Bio (ZURA) United States $0.131B 0.00
Fate Therapeutics (FATE) United States $0.130B 0.00
Genelux (GNLX) United States $0.126B 0.00
Seer (SEER) United States $0.124B 0.00
Seres Therapeutics (MCRB) United States $0.123B 0.00
Skye Bioscience (SKYE) United States $0.120B 0.00
Oncolytics Biotech (ONCY) Canada $0.120B 0.00
Sangamo Therapeutics (SGMO) United States $0.119B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.118B 0.00
TuHURA Biosciences (HURA) United States $0.114B 0.00
BioHarvest Sciences (BHST) Canada $0.114B 0.00
Actuate Therapeutics (ACTU) United States $0.113B 0.00
Contineum Therapeutics (CTNM) United States $0.113B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.111B 0.00
Citius Oncology (CTOR) United States $0.109B 0.00
HilleVax (HLVX) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.103B 0.00
Coherus Oncology (CHRS) United States $0.102B 0.00
Climb Bio (CLYM) United States $0.102B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.101B 0.00
OKYO Pharma (OKYO) $0.101B 0.00
Cellectis S.A (CLLS) France $0.101B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.097B 0.00
Connect Biopharma Holdings (CNTB) United States $0.096B 0.00
Entera Bio (ENTX) Israel $0.093B 0.00
Immunic (IMUX) United States $0.092B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.091B 0.00
XBiotech (XBIT) United States $0.091B 0.00
Invivyd (IVVD) United States $0.090B 0.00
BeyondSpring (BYSI) United States $0.088B 0.00
Pliant Therapeutics (PLRX) United States $0.088B 0.00
Elutia (ELUT) United States $0.087B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Whitehawk Therapeutics (WHWK) United States $0.085B 0.00
Cabaletta Bio (CABA) United States $0.085B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.084B 0.00
TELA Bio (TELA) United States $0.084B 0.00
Immix Biopharma (IMMX) United States $0.083B 0.00
Adagene (ADAG) China $0.082B 0.00
MiNK Therapeutics (INKT) United States $0.081B 0.00
EXoZymes (EXOZ) United States $0.077B 0.00
IGM Biosciences (IGMS) United States $0.077B 0.00
Alto Neuroscience (ANRO) United States $0.075B 0.00
VistaGen Therapeutics (VTGN) United States $0.074B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.074B 0.00
Oncobiologics (OTLK) United States $0.073B 0.00
Celularity (CELU) United States $0.073B 0.00
Biomea Fusion (BMEA) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
Quantum Biopharma (QNTM) Canada $0.068B 0.00
Cue Biopharma (CUE) United States $0.068B 0.00
Opus Genetics (IRD) United States $0.067B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.067B 0.00
Forte Biosciences (FBRX) United States $0.067B 0.00
Applied Therapeutics (APLT) United States $0.065B 0.00
Repare Therapeutics (RPTX) Canada $0.065B 0.00
CervoMed (CRVO) United States $0.064B 0.00
Sutro Biopharma (STRO) United States $0.064B 0.00
Werewolf Therapeutics (HOWL) United States $0.063B 0.00
Adicet Bio (ACET) United States $0.063B 0.00
Scilex Holding (SCLX) United States $0.062B 0.00
Ikena Oncology (IKNA) United States $0.061B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.060B 0.00
MediciNova (MNOV) United States $0.060B 0.00
Atara Biotherapeutics (ATRA) United States $0.060B 0.00
Artiva Biotherapeutics (ARTV) United States $0.058B 0.00
InflaRx (IFRX) Germany $0.058B 0.00
Adverum Biotechnologies (ADVM) United States $0.058B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
INmune Bio (INMB) United States $0.057B 0.00
ABVC BioPharma (ABVC) United States $0.057B 0.00
Aligos Therapeutics (ALGS) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.055B 0.00
Renovaro (RENB) United States $0.055B 0.00
VTv Therapeutics (VTVT) United States $0.054B 0.00
Earth Science Tech (ETST) United States $0.053B 0.00
PDS Biotechnology (PDSB) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
Inovio Pharmaceuticals (INO) United States $0.051B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Exicure (XCUR) United States $0.050B 0.00
Jasper Therapeutics (JSPR) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.045B 0.00
Alterity Therapeutics - (ATHE) Australia $0.044B 0.00
PepGen (PEPG) United States $0.044B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.042B 0.00
CalciMedica (CALC) United States $0.042B 0.00
Pluri (PLUR) Israel $0.041B 0.00
Cognition Therapeutics (CGTX) United States $0.041B 0.00
Ovid Therapeutics (OVID) United States $0.039B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.037B 0.00
KALA BIO (KALA) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Radiopharm Theranostics - (RADX) Australia $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
CAMP4 Therapeutics (CAMP) United States $0.032B 0.00
Clearside Biomedical (CLSD) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Clene (CLNN) United States $0.032B 0.00
OnKure Therapeutics (OKUR) United States $0.031B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.031B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.030B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.028B 0.00
Generation Bio (GBIO) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
ALX Oncology Holdings (ALXO) United States $0.027B 0.00
Q32 Bio (QTTB) United States $0.027B 0.00
FibroBiologics (FBLG) United States $0.027B 0.00
Rani Therapeutics Holdings (RANI) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Moleculin Biotech (MBRX) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Longeveron (LGVN) United States $0.023B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Cadrenal Therapeutics (CVKD) United States $0.022B 0.00
Cingulate (CING) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
Synlogic (SYBX) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Rallybio (RLYB) United States $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.018B 0.00
Passage Bio (PASG) United States $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
Equillium (EQ) United States $0.015B 0.00
Promis Neurosciences (PMN) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Synaptogenix (TAOX) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
HOOKIPA Pharma (HOOK) United States $0.014B 0.00
COSCIENS Biopharma (CSCI) Canada $0.014B 0.00
NextCure (NXTC) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
180 Life Sciences (ATNF) United States $0.011B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Novogen (KZIA) Australia $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
X4 Pharmaceuticals (XFOR) United States $0.008B 0.00
Artelo Biosciences (ARTL) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Windtree Therapeutics (WINT) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
LakeShore Biopharma (LSB) China $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00